CVS Health Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
CVS Health (CVS) PT Raised to $100 at RBC Capital
November 7, 2018 7:11 AM ESTRBC Capital analyst George Hill raised the price target on CVS Health (NYSE: CVS) to $100.00 (from $99.00) while maintaining a Outperform rating.
... MoreCVS Health (CVS) Tops Q3 EPS by 2c
November 6, 2018 6:56 AM ESTCVS Health (NYSE: CVS) reported Q3 EPS of $1.73, $0.02 better than the analyst estimate of $1.71. Revenue for the quarter came in at $47.3 billion versus the consensus estimate of $47.2 billion.
GUIDANCE:
CVS Health sees FY2018 EPS of $6.98-$7.08, versus the consensus of... More
